On-demand education
Incorporating DecisionDx-Melanoma into Clinical Practice: Molecular Information for Personalized Management Decisions
DecisionDx-Melanoma: Predicting Individualized Risk of Recurrence
31-GEP: Sentinel Lymph Node Biopsy Guidance
Castle Biosciences - Revolutionizing Gene Expression Profiling in Clinical Management of Dermatologic Cancers
Use of a Genomic-based Prognostic Tool to Inform Clinical Decisions for Patients with Cutaneous Melanoma
This activity is designed to address the following core and team competencies: Patient Care, Medical Knowledge, Practice-based learning and improvement, Interprofessional Collaboration, and Roles & Responsibilities.
CME/CE: (Credit Expiration Date: July 31st, 2021)